Novel PARP inhibitors with potent antitumor activity as single-agent and combination therapies

被引：7
|
作者：
Wang, Bing
Chu, Daniel
Feng, Ying
Yu, Xin
Myers, Peter
Post, Leonard
Shen, Yucliao
机构：
来源：
MOLECULAR CANCER THERAPEUTICS | 2009年 / 8卷 / 12期
关键词：
D O I：
10.1158/1535-7163.TARG-09-A121
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A121
引用
收藏
页数：3
相关论文
共 50 条
  • [21] REVIEW OF ETOPOSIDE SINGLE-AGENT ACTIVITY
    SCHMOLL, H
    CANCER TREATMENT REVIEWS, 1982, 9 : 21 - 30
  • [22] Identification and preclinical characterisation of VER-250840, a potent, selective Chk1 inhibitor with in vivo oral single-agent antitumor activity
    Wayne, Joanne
    Stokes, Stephen
    Foloppe, Nicolas
    Browne, Helen
    Brooks, Teresa
    Benwell, Karen
    Baker, Lisa
    Daniels, Zoe
    Fiumana, Andrea
    Graham, Christopher
    Macias, Alba
    Maddox, Daniel
    McKenna, Sean
    Northfield, Christopher
    Ray, Stuart
    Simmonite, Heather
    Stefaniak, Emma
    Webb, Paul
    Wood, Mike
    Massey, Andrew
    MOLECULAR CANCER THERAPEUTICS, 2018, 17 (01)
  • [23] SCH 2047069, a Novel Oral Kinesin Spindle Protein Inhibitor, Shows Single-Agent Antitumor Activity and Enhances the Efficacy of Chemotherapeutics
    Basso, Andrea D.
    Liu, Ming
    Dai, Chaoyang
    Gray, Kimberly
    Nale, Lissette
    Tevar, Seema
    Lee, Suining
    Liang, Lianzhu
    Ponery, Abdul
    Yaremko, Bohdan
    Smith, Elizabeth
    Tang, Huadong
    Sheth, Payal R.
    Siddiqui, M. Arshad
    Hicklin, Daniel J.
    Kirschmeier, Paul
    MOLECULAR CANCER THERAPEUTICS, 2010, 9 (11) : 2993 - 3002
  • [24] SINGLE-AGENT AND COMBINATION THERAPY OF ESSENTIAL-HYPERTENSION
    WEBER, MA
    DRAYER, JIM
    AMERICAN HEART JOURNAL, 1984, 108 (02) : 311 - 316
  • [25] Single-agent and combination biologics in acute myeloid leukemia
    Richard-Carpentier, Guillaume
    DiNardo, Courtney D.
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2019, : 548 - 556
  • [26] Glutamatergic Pathway Targeting in Melanoma: Single-Agent and Combinatorial Therapies
    Lee, Hwa Jin
    Wall, Brian A.
    Wangari-Talbot, Janet
    Shin, Seung-Shick
    Rosenberg, Stephen
    Chan, Joseph L-K.
    Namkoong, Jin
    Goydos, James S.
    Chen, Suzie
    CLINICAL CANCER RESEARCH, 2011, 17 (22) : 7080 - 7092
  • [27] THE ACTIVITY OF SINGLE-AGENT CARBOPLATIN IN ADVANCED SEMINOMA
    HORWICH, A
    DEARNALEY, DP
    AHERN, R
    MASON, M
    THOMAS, G
    JAY, G
    NICHOLLS, J
    EUROPEAN JOURNAL OF CANCER, 1992, 28A (8-9) : 1307 - 1310
  • [28] Trends in complexity of single-agent and combination therapies for solid tumor cancers approved by the US Food and Drug Administration
    Chen, Emerson Y.
    Rai, Manoj
    Tadikonda, Yash
    Roy, Preeyam
    Nollner, Dakota W.
    Chitkara, Akshit
    Hamilton, Julia
    Thawani, Rajat
    ONCOLOGIST, 2024,
  • [29] A novel Aurora B kinase inhibitor with potent anticancer activity either as a single agent or in combination with chemotherapy.
    Nair, JS
    Tse, A
    Keen, N
    Schwartz, GK
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 851S - 851S
  • [30] Preclinical development of aplidine, a novel marine-derived agent with potent antitumor activity
    Faircloth, G
    Grant, W
    Nam, S
    Jimeno, J
    Manzanares, I
    Rinehart, KL
    ANNALS OF ONCOLOGY, 1998, 9 : 34 - 34
12345